Efficacy of Ab Interno Revision for Trabeculectomy Bleb Failure Using a Minimally Invasive Approach: A Prospective Study.
Snehi Sagarika, Thattaruthody Faisal, Singh Jyoti, Singh Ashok, Pandav Surinder S, Kaushik Sushmita
AI Summary
This study found that Ab Interno Bleb Revision (AIBR) effectively restores failed trabeculectomy blebs, significantly lowering IOP and medication needs, offering a safe, minimally invasive option for patients.
Abstract
Précis: Ab interno bleb revision using the Grover and Fellman spatula offers potential benefits in improved intraocular pressure control and spares the conjunctiva for enhanced bleb management.
Purpose
This study aimed to evaluate the safety and effectiveness of Ab-Interno Bleb Revision (AIBR) for treating failed trabeculectomy blebs.
Methods
This noncomparative case series enrolled glaucoma patients with failed trabeculectomy blebs who underwent AIBR and were followed up for 1 year. Eligible patients received subconjunctival Mitomycin C 0.1 mL of 0.2 mg/mL (20 μg) 5 days before the AIBR, performed using the Grover and Fellman spatula. The primary outcome measures were intraocular pressure (IOP) and the usage of IOP-lowering medications 1 year after the procedure. Secondary outcomes included the procedure's failure rate and complications. Complete success was defined as achieving an IOP between 5 and 21 mm Hg without medication, while qualified success required additional medical treatment.
Results
The study comprised 23 eyes from 23 patients, having a mean age of 59.66±14.93 years. Preoperatively, the mean IOP was 23.54±10.7 mm Hg, and the mean antiglaucoma medication requirement was 3.99±0.65, both significantly reduced to 15.7±6.9 mm Hg ( P =0.009) and 1.26±1.2 ( P <0.001) at 1 year, respectively. Overall, 19 eyes (82.6%) achieved success (complete success: 39.2%, qualified success: 43.4%), while in 4 (17.4%) patients, the procedure failed (IOP >21 mm Hg). 5 patients had transient hyphema, but there were no sight-threatening complications such as hypotony or choroidal detachment.
Conclusions
Ab-Interno Bleb Revision (AIBR) is a safe, effective, and minimally invasive intervention for managing failed trabeculectomy blebs. By eliminating the need to reopen the conjunctiva, this technique offers a promising alternative for the treatment of this challenging condition.
MeSH Terms
Shields Classification
Key Concepts5
Ab-Interno Bleb Revision (AIBR) using the Grover and Fellman spatula is a safe, effective, and minimally invasive intervention for managing failed trabeculectomy blebs.
In a noncomparative case series of 23 eyes from 23 patients, Ab-Interno Bleb Revision (AIBR) significantly reduced mean intraocular pressure (IOP) from 23.54±10.7 mm Hg preoperatively to 15.7±6.9 mm Hg at 1 year (P =0.009).
In a noncomparative case series of 23 eyes from 23 patients, Ab-Interno Bleb Revision (AIBR) significantly reduced the mean antiglaucoma medication requirement from 3.99±0.65 preoperatively to 1.26±1.2 at 1 year (P <0.001).
In a noncomparative case series of 23 eyes from 23 patients, Ab-Interno Bleb Revision (AIBR) achieved an overall success rate of 82.6% (19 eyes) at 1 year, with complete success (IOP between 5 and 21 mm Hg without medication) in 39.2% and qualified success (with additional medical treatment) in 43.4%.
In a noncomparative case series of 23 eyes from 23 patients, Ab-Interno Bleb Revision (AIBR) resulted in transient hyphema in 5 patients, but no sight-threatening complications such as hypotony or choroidal detachment were observed.
Related Articles5
Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study-a randomised clinical trial.
Randomized Controlled TrialHypotony Failure Criteria in Glaucoma Surgical Studies and Their Influence on Surgery Success.
Systematic ReviewPredicting Glaucoma Surgical Outcomes Using Neural Networks and Machine Learning on Electronic Health Records.
Observational StudyFactors influencing the outcomes of trabeculectomy, conventional canaloplasty, and mitomycin C augmented canaloplasty.
Observational StudyTreatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up.
Randomized Controlled TrialIs this article assigned to the wrong chapter(s)? Let us know.